In the businesses in which we compete, we hold a number one or number two position in each of those categories, I won't go through each of these but you can see it on the left hand side that, about half of our categories, we hold the number one position and a little more than half categories, we hold the number two position. So, we hold a very competitive place in the marketplace. And you know we attribute that to the competitive differentiation in the value proposition that we bring across that Care Continuum.
If you look at fiscal 2011, and you breakdown our revenue, first by reporting segment, we organize our business into three segments, North America Acute Care which is focused on the hospital. North American, Post-Acute, where we have three businesses, our Respiratory Care business and then also extended care and home care and the Post-Acute Setting and then our international business, which has a combination of all of those, outside of North America.
You can see that little over 60% comes from North America Acute, of that about a quarter from international and 13% in our Post-Acute business. If you break that down by business model, as I mentioned earlier, we have rental revenue and also revenue from sales, a combination of capital software and services. You can see that 70% of it is from the capital software and services and about a third of it from rental.
And then, finally if you break it down by geography, you can see the three quarters of revenue is generated in North America, 17% Europe and a little less than 10% in the rest of the world.We recognized that there is, multiple challenges in today’s environment. And we think we have responses from many of those. I’m not going to walk through every one of these points, but certainly, you know, one of our challenges today is to provide more care with fewer resources. And we believe that our product offerings and our services are differentiated in terms of the outcomes that they can provide. We do believe that we offer a return on investment. We believe that we are an investment versus the cost and that we have clinical data to support that that we can prove outcomes and reduce operating expenses.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV